Inventor · disambiguated record
Ian Rilatt
Also filed as: RILATT IAN
8 granted patents·7 pending applications·13 citations·filing 2014–2022
81Inventor score
Files withPF MEDICAMENT15
Top patents by PatentIndex Score
15 records- 0188US10633448B2IGF-1R antibody-drug-conjugate and its use for the treatment of cancerPF MEDICAMENT·Filed 2015·Granted Apr 28, 2020·4 cites·21 claims
- 0285US11517625B2Antibody-drug-conjugate and its use for the treatment of cancerPF MEDICAMENT·Filed 2020·Granted Dec 6, 2022·1 cites·10 claims
- 0385US10858423B2Composition for the treatment of IGF-1R expressing cancerPF MEDICAMENT·Filed 2016·Granted Dec 8, 2020·3 cites·14 claims
- 0484US11219693B2Antibody-drug-conjugate and its use for the treatment of cancerPF MEDICAMENT·Filed 2019·Granted Jan 11, 2022·1 cites·26 claims
- 0583US10912841B2Antibody-drug-conjugate and its use for the treatment of cancerPF MEDICAMENT·Filed 2018·Granted Feb 9, 2021·1 cites·17 claims
- 0682US10314921B2Antibody-drug-conjugate and its use for the treatment of cancerPF MEDICAMENT·Filed 2015·Granted Jun 11, 2019·3 cites·23 claims
- 0780US2023002316A1Derivatives of dolastatin 10 and auristatinsPF MEDICAMENT·Filed 2022·Application pending·0 cites
- 0876US11918656B2Antibody-drug-conjugate and its use for the treatment of cancerPF MEDICAMENT·Filed 2021·Granted Mar 5, 2024·0 cites·11 claims
- 0972US2021107868A1Derivatives of dolastatin 10 and auristatinsPF MEDICAMENT·Filed 2020·Application pending·0 cites
- 1067US2020010414A1Derivatives of dolastatin 10 and auristatinsPF MEDICAMENT·Filed 2019·Application pending·0 cites
- 1163US2016068566A1Derivatives of dolastatin 10 and auristatinsPF MEDICAMENT·Filed 2014·Application pending·0 cites
- 1263US2016068567A1Derivatives of dolastatin 10 and auristatinsPF MEDICAMENT·Filed 2014·Application pending·0 cites
- 1363US2016083420A1Derivatives of dolastatin 10 and auristatinsPF MEDICAMENT·Filed 2014·Application pending·0 cites
- 1462US2018222858A1Derivatives of dolastatin 10 and auristatinsPF MEDICAMENT·Filed 2017·Application pending·0 cites
- 1559US11661457B2IGF-1R antibody-drug-conjugate and its use for the treatment of cancerPF MEDICAMENT·Filed 2020·Granted May 30, 2023·0 cites·23 claims
Join the waitlist — get patent alerts
Get an alert when Ian Rilatt files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →